CSM Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
CSM Advisors's LLY Position: Q2 2026 in Review
CSM Advisors reduced its Eli Lilly (LLY) stake by 5.5% in Q2 2026, selling an estimated $1.64M and leaving 27,478 shares worth $33M. The position accounts for 0.7% of the portfolio, ranked #32.
CSM Advisors first reported a position in LLY in Q2 2021 and has held it in 21 quarters since. 4,599 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- CSM Advisors held 27,478 shares of Eli Lilly worth $33M as of Q2 2026.
- CSM Advisors sold 1,610 Eli Lilly shares in Q2 2026, an estimated $1.64M.
- Eli Lilly made up 0.7% of CSM Advisors's portfolio in Q2 2026, its #32 holding.
- CSM Advisors first reported a position in Eli Lilly in Q2 2021 and has held it in 21 quarters since.
- 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on CSM Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.